Coexisting Lung Cancer and Pulmonary Tuberculosis: A Comprehensive Review From Incidence to Management
Cancer Reports · 2025-05 · 8 (5)
DOI: 10.1002/cnr2.70213 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Reports, online erschienen am 10.05.2025. Verfasst von Wendi Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, Guangzhou Key Laboratory of Tuberculosis Research, Guangzhou Chest Hospital, Institute of Tuberculosis, …. Hauptthemen laut MEDLINE: Lung Neoplasms, Tuberculosis, Pulmonary. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Municipal Science and Technology Project.
Abstract (Originalsprache)
Background
Globally, infections account for 10% of new cancer cases, and cancer can compromise the immune system, increasing the risk of infections. With advances in cancer treatment, widespread use of immunotherapy, and prolonged survival of cancer patients, the coexistence of tuberculosis (TB) and cancer is becoming increasingly common in clinical settings.
Aim
This review aims to explore the interaction between tuberculosis (TB) and tumors, particularly lung cancer (LC), and to identify appropriate clinical management approaches.
Results
LC patients with a history of TB have higher adjusted risk ratios for both all‐cause and cancer‐specific 3‐year mortality compared to those without a history of TB. TB may elevate the risk of developing tumors through mechanisms such as chronic inflammation, altered immune responses, and DNA damage. Conversely, cancer patients, whether due to the disease itself or immune dysfunction caused by anti‐tumor treatments, may be more susceptible to TB. The coexistence of TB and tumors presents significant challenges in clinical management, making the development of treatment strategies and quality‐of‐life improvements crucial.
Conclusion
There is a close relationship between TB and cancer, with TB potentially serving as a risk factor for cancer, and cancer influencing susceptibility to TB. Effective clinical management is essential to enhance treatment strategies and improve the quality of life for patients with both TB and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Respiratory Disease, Guangzhou Key Laboratory of Tuberculosis Research, Guangzhou Chest Hospital, Institute of Tuberculosis, Guangzhou Medical University, Guangzhou, P. R. China.
- Department of Children's Psychological and Rehabilitation, Shen Zhen Maternity and Child Health Hospital, Southern Medical University, Shenzhen, P. R. China.
- Department of Oncology, Guangzhou Red Cross Hospital, Guangzhou, P. R. China.
ORCID-Profile: Ning Su
Förderung
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Zhou, W., Lu, H., Lin, J., Zhu, J., Liang, J., Xie, Y., Hu, J., & Su, N. (2025). Coexisting Lung Cancer and Pulmonary Tuberculosis: A Comprehensive Review From Incidence to Management. Cancer Reports, 8(5). https://doi.org/10.1002/cnr2.70213
Vancouver
Zhou W, Lu H, Lin J, Zhu J, Liang J, Xie Y, et al. Coexisting Lung Cancer and Pulmonary Tuberculosis: A Comprehensive Review From Incidence to Management. Cancer Reports. 2025;8(5). doi:10.1002/cnr2.70213
BibTeX
@article{Zhou2025,
author = {Zhou, Wendi and Lu, Hongxu and Lin, Jiamin and Zhu, Jialou and Liang, Jizhen and Xie, Yalin and Hu, Jinxing and Su, Ning},
title = {Coexisting Lung Cancer and Pulmonary Tuberculosis: A Comprehensive Review From Incidence to Management},
journal = {Cancer Reports},
year = {2025},
volume = {8},
number = {5},
doi = {10.1002/cnr2.70213}
}
EUVIMED